Neuropharmacological aspects of cognitive neurorehabilitation in epilepsy.
The role of CNS neuromodulators in cognitive neurorehabilitation can be related to two main issues: 1) the negative impact on cognition of drug categories prescribed for different neurologic symptoms, such as spasticity, extrapyramidal symptoms, or epileptic seizures; 2) their possible role in neuroprotection and amelioration of the cognitive status of the patient, especially attention and memory. This paper reviews different pharmacological aspects of cognitive neurorehabilitation in epilepsy.
Mula
Marco
M
Department of Neurology, Amedeo Avogadro University, Novara, Italy.
Trimble
Michael R
MR
D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D001921:Brain / Q000098:blood supply / Q000187:drug effects / Q000503:physiopathology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003072:Cognition Disorders / Q000139:chemically induced / Q000188:drug therapy* / Q000534:rehabilitation; D015928:Cognitive Behavioral Therapy / Q000379:methods; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000627:therapeutic use
D000927:Anticonvulsants; D000697:Central Nervous System Stimulants; D018696:Neuroprotective Agents; D018377:Neurotransmitter Agents; D018697:Nootropic Agents